Literature DB >> 22042180

Depression in patients with refractory temporal lobe epilepsy.

Eleonora Borges Gonçalves1, Fernando Cendes.   

Abstract

OBJECTIVE: To evaluate the comorbidity of depressive disorders in patients with refractory temporal lobe epilepsy (TLE).
METHOD: We evaluated 25 consecutive patients with refractory TLE (16 women and 9 men), using semi-structured psychiatric interviews, according to the International Classification of Diseases (ICD-10), and the Beck Depression Inventory.
RESULTS: Seventeen of 25 patients (68%) had depressive disorder: 6 with dysthymia, three with major depressive episodes and 8 with recurrent depressive disorders. Two (8%) were diagnosed with mixed anxiety and depression. Only 5 of 17 patients (29.4%) were previously diagnosed with depressive disorder and received prior antidepressant treatment. Duration of epilepsy was significantly higher in patients with depressive disorder (p=0.016), but there was no relationship between depression and seizure frequency.
CONCLUSION: This study confirmed that depressive disorders are common and underdiagnosed in patients with TLE refractory to AEDs. Patients with longer duration of epilepsy are at higher risk of having depression.

Entities:  

Mesh:

Year:  2011        PMID: 22042180     DOI: 10.1590/s0004-282x2011000600010

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  3 in total

1.  Absence Epilepsy: The Tail WAGs the Rat.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2014-05       Impact factor: 7.500

2.  GABAergic alterations in neocortex of patients with pharmacoresistant temporal lobe epilepsy can explain the comorbidity of anxiety and depression: the potential impact of clinical factors.

Authors:  Luisa Rocha; Mario Alonso-Vanegas; Iris E Martínez-Juárez; Sandra Orozco-Suárez; David Escalante-Santiago; Iris Angélica Feria-Romero; Cecilia Zavala-Tecuapetla; José Miguel Cisneros-Franco; Ricardo Masao Buentello-García; Jesús Cienfuegos
Journal:  Front Cell Neurosci       Date:  2015-01-05       Impact factor: 5.505

3.  Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy.

Authors:  Eleonora Borges Gonçalves; Tania Aparecida Marchiori de Oliveira Cardoso; Clarissa Lin Yasuda; Fernando Cendes
Journal:  J Int Med Res       Date:  2017-09-27       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.